Print version of this report
TGA Action ID RC-2026-RN-00196-1
Type of Product Medical Device
Product Name/Description Medtronic Sphere-9 Catheter

Model Number: AFR-00001
ARTG Number 468766
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action Medtronic has observed an unanticipated device interaction inducing ventricular tachycardia (VT) or ventricular fibrillation (VF) during radiofrequency (RF) therapy with the Medtronic Sphere-9 catheter in patients who have a Biotronik Implantable Cardioverter Defibrillator (ICD) or Biotronik Cardiac Resynchronisation Therapy-Defibrillator (CRT-D) implanted.

Through 20 February 2026, a total of 33 incidents of VT or VF induction have occurred during RF therapy delivery with the Medtronic Sphere-9 catheter in patients with a Biotronik ICD or CRT-D. The induced ventricular arrhythmias have either self-terminated or required external defibrillation, and there have been no reported deaths or serious injuries associated with this device interaction.
Instructions for Customers/Users Customers are to:
- Follow the procedure recommendations listed in the Customer Letter in addition to the Instructions for Use when using a Sphere-9 catheter with a concomitant Biotronik ICD/CRT-D.

This action has been closed out on 06/07/2026
Action Commencement Date 23/03/2026
Responsible Entity Medtronic Australasia Pty Ltd
Contact Information 0417 406 225 - Alex Jackson, Medtronic Australasia